Biography:
Adam McBride is the CEO of Eden, leading the charge in transforming metabolic health through accessible, evidence-based solutions. With a career spanning product innovation at major corporations and entrepreneurial ventures, he combines professional expertise with personal experience—having lost 58 pounds using GLP-1 therapies—to drive Eden’s mission. Adam holds a Master’s degree from Harvard University and a Bachelor’s from California State University-San Bernardino. A dedicated endurance athlete and family man, he is a passionate advocate for sustainable health, vitality, and longevity, working to make cutting-edge metabolic treatments available to all.
Enhancing workplace productivity through health solutions: Data-driven insights on the impact of GLP-1 medications on focus, productivity, and absenteeism